Company Analysis

Standard BioTools Inc. (LAB)

Nasdaq: LAB · Laboratory Analytical Instruments · Boston, MA · filing with the SEC since 2002
Grade3.4
◀ Past 1.4● Present 3.4▶ Future 5.3
1 est.

The company now

Standard BioTools Inc. is classed by the SEC under Laboratory Analytical Instruments (industry code 3826), based in Boston, MA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $85 million and a loss of $75 million (its filed statements).

From its filings and filed figures; the desk's account of it is not written yet.

Where the revenue comes from

fiscal 2025, as filed

Revenue by product, fiscal 2025

ProductFiscal 2025Fiscal 2024Share of revenue
Consumables$36.2M$40.5M42.5%
Instruments$25.4M$24.9M29.8%
Services and Other Revenue$23.7M$25.6M27.7%

Revenue by region, fiscal 2025

RegionFiscal 2025Fiscal 2024Share of revenue
EMEA$36.0M$35.6M42.2%
Americas$30.6M$37.4M35.8%
Asia Pacific$18.8M$18.0M22.0%

As tagged in its annual report (Form 10-K, filed Mar 16, 2026 ↗), read from the SEC's financial statement data sets. The year before is the figure the record holds for the prior fiscal year.

The desk's written account of this company, its Past, Present and Future, is not on file yet.

How the company works

The desk has not read this company's annual report yet.

The record in brief

The desk has not written this company's report yet.

SI Assistanton LAB · research, not advice